{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:05Z","timestamp":1793082725719,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006711","name":"Changzhou University","doi-asserted-by":"publisher","award":["ZMF23020004"],"award-info":[{"award-number":["ZMF23020004"]}],"id":[{"id":"10.13039\/501100006711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20230636"],"award-info":[{"award-number":["BK20230636"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CJ20230029"],"award-info":[{"award-number":["CJ20230029"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007131","name":"Changzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CJ20240044"],"award-info":[{"award-number":["CJ20240044"]}],"id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109195","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:11:56Z","timestamp":1762272716000},"page":"109195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin"],"prefix":"10.1016","volume":"166","author":[{"given":"Hongyan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxuan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.109195_bb0005","first-page":"205","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109195_bb0010","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109195_bb0015","doi-asserted-by":"crossref","first-page":"1941710","DOI":"10.1080\/19490976.2021.1941710","article-title":"\u201cDriver-passenger\u201d bacteria and their metabolites in the pathogenesis of colorectal cancer","volume":"13","author":"Avril","year":"2021","journal-title":"Gut Microbes"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109195_bb0020","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109195_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109195_bb0030","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/ijms24021702","article-title":"Current targeted therapy for metastatic colorectal cancer","volume":"24","author":"Ohishi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109195_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.20.02088","article-title":"Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study","volume":"39","author":"Tabernero","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109195_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107300","article-title":"PI3K\/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression","volume":"206","author":"Guo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.109195_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in cancer: Mediator and more","volume":"59","author":"Revathidevi","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109195_bb0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a therapeutic target for cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109195_bb0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109195_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcmgh.2020.04.007","article-title":"Are Wnt\/\u03b2-Catenin and PI3K\/AKT\/mTORC1 distinct pathways in colorectal cancer?","volume":"10","author":"Prossomariti","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109195_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbadis.2017.10.033","article-title":"CCR6 promotes tumor angiogenesis via the AKT\/NF-\u03baB\/VEGF pathway in colorectal cancer","volume":"1864","author":"Zhu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109195_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signaling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109195_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-019-1049-7","article-title":"CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"38","author":"Pan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109195_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3892\/ijo.2022.5472","article-title":"Blocking the Wnt\/\u03b2-catenin signaling pathway to treat colorectal cancer: strategies to improve current therapies","volume":"62","author":"Chen","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2025.109195_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/103830","article-title":"Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma","volume":"2013","author":"Zhou","year":"2013","journal-title":"Int. J. Hepatol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109195_bb0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/13543784.2019.1676726","article-title":"Targeting AKT for cancer therapy","volume":"28","author":"Shariati","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2025.109195_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117334","article-title":"Structural requirements of isoform-specific inhibitors of Akt: Implications in the development of effective cancer treatment strategies","volume":"287","author":"Adon","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109195_bb0100","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1021\/acs.jmedchem.4c00075","article-title":"Akt inhibitor advancements: From capivasertib approval to covalent-allosteric promises","volume":"67","author":"Pervanidis","year":"2024","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109195_bb0105","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109195_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40265-024-01998-6","article-title":"Capivasertib: First approval","volume":"84","author":"Shirley","year":"2024","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109195_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004881","article-title":"S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109195_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103640","article-title":"Podophyllotoxin derivatives targeting tubulin: An update (2017\u20132022)","volume":"28","author":"Xu","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109195_bb0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/biom11040603","article-title":"Podophyllotoxin: History, recent advances and future prospects","volume":"11","author":"Shah","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.109195_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115039","article-title":"Advances of podophyllotoxin and its derivatives: Patterns and mechanisms","volume":"200","author":"Shi","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109195_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114145","article-title":"Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy","volume":"158","author":"Motyka","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109195_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176968","article-title":"Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance","volume":"983","author":"Lv","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109195_bb0145","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jnatprod.3c00384","article-title":"Modified podophyllotoxin phenoxyacetamide phenylacetate derivatives: Tubulin\/AKT1 dual-targeting and potential anticancer agents for human NSCLC","volume":"86","author":"Lin","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109195_bb0150","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.2147\/DDDT.S167382","article-title":"Synthesis and anticancer activity of dimeric podophyllotoxin derivatives","volume":"12","author":"Zi","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.109195_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112830","article-title":"Recent advances of podophyllotoxin\/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010\u22122020)","volume":"208","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109195_bb0160","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.bmc.2007.08.020","article-title":"Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry","volume":"15","author":"Imperio","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109195_bb0165","doi-asserted-by":"crossref","first-page":"13108","DOI":"10.1021\/acs.chemrev.1c00991","article-title":"1,2,3-Triazole and its analogues: New surrogates for diazo compounds","volume":"122","author":"Akter","year":"2022","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109195_bb0170","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"issue":"33","key":"10.1016\/j.bioorg.2025.109195_bb0175","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"Satyanarayana","year":"2009","journal-title":"Oncogene"},{"issue":"11\u221212","key":"10.1016\/j.bioorg.2025.109195_bb0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109195_bb0185","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/acs.jnatprod.2c00457","article-title":"Mechanisms of Biochanin a alleviating PM2.5 organic extracts-induced EMT of A549 cells through the PI3K\/Akt pathway","volume":"85","author":"Wang","year":"2022","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109195_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-016-0487-8","article-title":"Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer","volume":"36","author":"Xu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109195_bb0195","first-page":"7351","article-title":"Gefitinib inhibits malignant melanoma cells through the VEGF\/AKT signaling pathway","volume":"17","author":"Wan","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109195_bb0200","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11095-013-1278-y","article-title":"A novel method for determining the solubility of small molecules in aqueous media and polymer solvent systems using solution calorimetry","volume":"31","author":"Fadda","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.109195_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107981","article-title":"Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT\/mTOR and MEK\/ERK pathways","volume":"154","author":"Han","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109195_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108307","article-title":"Design, synthesis and antitumor activity evaluation of novel modified 18\u03b2-glycyrrhetinate derivatives as PPAR\u03b3 agonists","volume":"157","author":"Lin","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109195_bb0215","article-title":"Natural isoflavone glabridin targets PI3K\u03b3 as an adjuvant to increase the sensitivity of MDA-MB-231 to tamoxifen and DU145 to paclitaxel","volume":"236","author":"Lin","year":"2024","journal-title":"J. Steroid Biochem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109195_bb0220","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New cocking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109195_bb0225","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109195_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154894","article-title":"A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3","volume":"126","author":"Han","year":"2024","journal-title":"Phytomedicine"}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.109235","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:05:11Z","timestamp":1768449911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"alternative-id":["S0045206825010752"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109195","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109195"}}